SCHEMBL19980775

SCHEMBL19980775

Cc1ccccc1-c1cccc(-c2cnccn2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 1/20 0.48
NPY5R Q15761 1/20 0.42
CYP1A2 P05177 7/20 0.41
CYP3A4 P08684 4/20 0.41
CYP2D6 P10635 3/20 0.41
CYP17A1 P05093 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
CYP2C19 P33261 3/20 0.38
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
ADRA1D P25100 1/20 0.38
NPC1 O15118 1/20 0.38
MITF O75030 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6527857 0.88 DCTPP1 (0.45) DCTPP1NPY5RCYP1A2CYP17A1ADRA1A
SCHEMBL2556892 0.88 DCTPP1 (0.54) DCTPP1NPY5RCYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL28048584 0.86 DCTPP1 (0.52) DCTPP1NPY5RCYP1A2CYP3A4CYP2D6
SCHEMBL21128380 0.79 CYP17A1 (0.50) CYP1A2CYP3A4CYP2D6CYP17A1
SCHEMBL21090970 0.77 USP1 (0.38) DCTPP1CYP1A2ADRA1AADRA1BALOX5AP
SCHEMBL12853973 0.76 ALOX5AP (0.50) DCTPP1CYP1A2CYP2D6ADRA1AADRA1B
SCHEMBL12853984 0.76 ALOX5AP (0.50) DCTPP1CYP1A2CYP2D6ADRA1AADRA1B
SCHEMBL28129242 0.75 DCTPP1 (0.41) DCTPP1NPY5RCYP1A2CYP2D6CYP17A1
SCHEMBL17194890 0.75 MAPK1 (0.43) DCTPP1NPY5RCYP1A2CYP3A4CYP2D6
SCHEMBL17194971 0.75 P2RX7 (0.41) DCTPP1CYP1A2ADRA1AADRA1BALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10396299-B2 Organic electroluminescent devices and metal complex compounds UDC IRELAND LIMITED (IE) 2019-08-27 US disclosed
US-20180083208-A1 Organic Electroluminescent Devices and Metal Complex Compounds UDC IRELAND LTD (IE) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180083208-A1 Organic Electroluminescent Devices and Metal Complex Compounds EPCAM, TPR, L1CAM DCTPP1 2520/4885NPY5R 4552/4885CYP1A2 4519/4885
US-10396299-B2 Organic electroluminescent devices and metal complex compounds EPCAM, TPR, L1CAM DCTPP1 2520/4885NPY5R 4552/4885CYP1A2 4519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.